within Pharmacolibrary.Drugs.ATC.V;

model V04CM01
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 2.3999999999999997e-05,
    adminDuration  = 600,
    adminMass      = 0.1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0066,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0176,
    k12             = 0.55,
    k21             = 0.55
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V04CM01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Gonadorelin is a synthetic decapeptide identical to the naturally occurring gonadotropin-releasing hormone (GnRH). It stimulates the release of the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary. It is used diagnostically to evaluate pituitary function and rarely therapeutically. It is an approved drug for diagnostic use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported for healthy adult males after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Periti, P, Mazzei, T, &amp; Mini, E (2002). Clinical pharmacokinetics of depot leuprorelin. <i>Clinical pharmacokinetics</i> 41(7) 485–504. DOI:<a href=\"https://doi.org/10.2165/00003088-200241070-00003\">10.2165/00003088-200241070-00003</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12083977/\">https://pubmed.ncbi.nlm.nih.gov/12083977</a></p></li><li><p>Handelsman, DJ, &amp; Swerdloff, RS (1986). Pharmacokinetics of gonadotropin-releasing hormone and its analogs. <i>Endocrine reviews</i> 7(1) 95–105. DOI:<a href=\"https://doi.org/10.1210/edrv-7-1-95\">10.1210/edrv-7-1-95</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3007081/\">https://pubmed.ncbi.nlm.nih.gov/3007081</a></p></li><li><p>Sennello, LT, Finley, RA, Chu, SY, Jagst, C, Max, D, Rollins, DE, &amp; Tolman, KG (1986). Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration. <i>Journal of pharmaceutical sciences</i> 75(2) 158–160. DOI:<a href=\"https://doi.org/10.1002/jps.2600750211\">10.1002/jps.2600750211</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3083092/\">https://pubmed.ncbi.nlm.nih.gov/3083092</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V04CM01;
